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Abstract Nitric oxide (NO) has emerged as a major
modulator of cellular function in health and disease. In
addition to its well-known role as a mediator of smooth
muscle relaxation, a rapidly developing body of res-
earch suggests, paradoxically, that NO can have both
cytotoxic and cytoprotective effects. In this issue of
Neurogastroenterology and Motility, Choi et al. pro-
vide evidence that supports NO has a prosurvival effect
on interstitial cells of Cajal in the mouse stomach. The
objective of this short review is to place this interesting
report in the context of the current literature.
Keywords carbon monoxide, hemeoxygenase,
interstitial cells of Cajal, neuronal nitric oxide
synthase, nitric oxide.
INTRODUCTION
The paradigm shifting discovery that mammalian
cells have the capability of synthesizing the free
radical nitric oxide (NO) has led to an explosion of
research in the past decade to elucidate the role of
this molecule under physiological and pathophysio-
logical circumstances. NO has emerged as a funda-
mental signaling molecule regulating virtually every
critical cellular function, and a potent mediator of
cellular damage in a wide range of conditions.1 NO
has been implicated in both anti- and pro-apoptotic
pathways depending on the cell type and conditions.
At high concentrations, NO induces cell death during
ischemic injury or as a consequence of neurodegener-
ative diseases.2,3 At lower concentrations, NO appears
to be cytoprotective in neuronal cell lines.4,5 The
cytotoxicity attributed to NO involves the generation
of peroxynitrite, produced from the diffusion-con-
trolled reaction between NO and another free radical,
the superoxide anion. Peroxynitrite interacts with
lipids, DNA, and proteins via direct oxidative reac-
tions or via indirect, radical-mediated mechanisms.
These reactions trigger cellular responses ranging
from subtle modulations of cell signaling to over-
whelming oxidative injury, committing cells to nec-
rosis or apoptosis. Peroxynitrite generation appears to
play a crucial pathogenic mechanism in conditions
such as stroke, myocardial infarction, chronic heart
failure, diabetes, circulatory shock, chronic inflam-
matory diseases, cancer, and neurodegenerative disor-
ders. The neuroprotective effect of NO appears to be
mediated at least in part by a cyclic GMP/protein
kinase G (PKG) pathway.6,7 NO activates soluble
guanylyl cyclase, an enzyme that catalyzes synthesis
of cGMP from GTP. The mechanisms of PKG-medi-
ated antiapoptotic actions are an active area of
investigation. It is apparent that modulation of these
pathways has important therapeutic implications.
Under physiologic conditions NO has a well-des-
cribed function as an inhibitory neuromodulator in the
nervous system and mediator of smooth muscle relax-
ation in the cardiovascular system and gastrointestinal
tract. In this issue of Neurogastroenterology and
Motility Choi et al. continue the expansion of our
understanding of the many faces of NO’s function.8
The factors underlying the survival and maintenance
of interstitial cells of Cajal (ICC) are poorly understood.
A robust literature supports the role for ICC as
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pacemaker cells in the gut and consequentially their
pivotal role in regulating gastrointestinal motility.9,10
Loss of ICC is often associated with loss of neuronal
nitric oxide synthase (nNOS) in humans suggesting a
possible link. The aim of this study was to determine
the effect of neuronal NO on ICC in the mouse gastric
body. The volumes of ICC were determined in the
gastric body and in organotypic cultures using immuno-
histochemistry, laser scanning confocal microscopy
and three-dimensional reconstruction in transgenic
mice that do not express nNOS)/) and control mice.
Functionally, the nNOS )/) mouse demonstrates
delayed gastric emptying because of impaired pyloric
relaxation and diminished gastric motility.11 ICC
numbers were determined in primary cell cultures
after treatment with a NO donor or a NOS inhibitor.
The volumes of myenteric c-Kit immunoreactive (a
well-accepted marker for ICC) networks of ICC from
nNOS)/) mice were significantly reduced compared
with control mice. No significant differences in the
volumes of c-Kit positive ICC were observed in the
longitudinal muscle layers. ICC volumes were either
decreased or unaltered in the circular muscle layer
after normalization for volume of circular smooth
muscle. Importantly, the number of ICC was increased
after incubation with S-nitroso-N-acetylpenicillamine
(NO donor) and decreased by N(G)-nitro-L-arginine
(inhibitor of NOS). The authors conclude that neuro-
nally derived NO modulates ICC numbers and net-
work volume in the mouse gastric body. Thus, in this
mouse model NO appears to be a prosurvival factor
for ICC.
This paper is noteworthy for several reasons. First,
this is one of the first reports using a knockout mouse
model for nNOS to examine the relationship between
NO and ICC networks in the GI tract. Secondly, the
authors have developed a method to assess cell volume
and applied this to assess how the absence of neuro-
nally derived NO influences ICC network volume in
the mouse stomach. This represents a significant
addition to historic morphometric techniques. It is
relevant that his approach is generalizable to other cell
systems and will likely be a more sensitive method to
detect changes in cell volume when compared with
conventional morphometric approaches. Thirdly, the
authors data suggests that there are significant
regional differences in ICC numbers and networks in
the mouse stomach. This establishes the need for a
systematic assessment of ICC networks in other
regions of the stomach, and other areas of the gut
wall, and correlation with function.
Similar to other important contributions to the
literature, the observations reported in this paper raise
a number of interesting questions to be addressed in
future studies.
THE ANIMAL MODEL
The availability of transgenic mouse models in
which specific genes and their products are knocked
out has led to numerous important observations.
However, mice are well known to exhibit different
responses depending on the strain of the mouse and
in comparative studies with other species.12,13 This
places responsibility on the investigator to validate
the measurements of the relevant biomarkers in the
specific mouse strain being evaluated and correlate
these observations with relevant markers of function.
It also raises the issue of how generalizable the
observations are between species. For example, Choi
et al. observed that the volumes of myenteric c-Kit
immunoreactive networks of ICC from nNOS)/)
mice were significantly decreased compared with
control mice. ICC volumes were either decreased or
unchanged in the circular muscle layer after normal-
ization for volume of circular smooth muscle, and no
significant change in the volume of ICC were
observed in the longitudinal layer. In contrast, Iwa-
saki et al. observed a loss of c-Kit and nNOS
expression in the diabetic human antrum that was
limited to the circular muscle layer and did not
appear to involve the myenteric plexus.14 Thus, the
general observation that decreased c-Kit immunore-
activity (ICC) is noted in the presence of reduced
nNOS expression holds but the specific areas of
involvement may be different either because of the
disease process or species differences. It is notewor-
thy that the nNOS)/) mouse model demonstrates an
increase in smooth muscle thickness through out the
stomach which raises the issue of a dilutional effect
with regard to the volumetric measurements of ICC.
The authors suggest that this is not the case because
changes in c-Kit immunoreactive ICC were greater
for ICC-myenteric plexus than ICC-circular muscle,
e.g. it would be anticipated that a dilutional effect
would be more detectable in the circular muscle
layer and this was not the case. The increase in
thickness of the muscle layer is thought to be related
to the proliferation of smooth muscle cells that is
observed in vascular smooth muscle when NO
availability is decreased.15 It is also relevant that
conventional knock out models sometimes produce
unexpected results because of inherent lethality that
occurs with loss of a particular gene product or a
tendency to obscure important modulatory effects of
the targeted gene, possibly because of adaptive
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responses that develop in these chronic models. This
has led to development of conditional knock out
models in which the targeted gene can be inhibited
under well-defined conditions established by the
investigator. The Cre-LoxP model has emerged as a
powerful technology for spatial and temporal control
genetic inactivation.16
THE MECHANISM(S) OF NO-MEDIATED
PROSURVIVAL ON ICC NETWORKS IN
THE MOUSE STOMACH
The authors considered a role for a cytoprotective
molecule such as glial derived neurotrophic factor
(GDNF) but were dissuaded by observations that
GDNF )/) and newborn c-ret)/) mice appear to have
largely intact ICC.17–19 Other mechanisms may
explain the apparent cytoprotective effect of NO
including increased cellular proliferation,20 decreased
cell death,21,22 and enhanced cell migration.23 NO
appears to increase cellular proliferation through
several mechanisms including S-nitrosylation or
S-nitroglutathione scavenging free radicals and inhibi-
tion of caspase-3, up-regulation of antiapoptotic bcl-2
and up-regulation of PI-3 kinase and via Raf/MEK/ERK
signaling pathways that are cGMP-independent.24
Other studies suggest that NO is cytoprotective
through a cGMP/PKG-dependent pathway and via
PI-3 kinase, MEK, PKA and CaMK.25 There is an
emerging evidence that peroxynitrite, at low concen-
trations, affords transient cytoprotection via inhibition
of PTEN a dual phosphatase that negatively regulates
the phosphatidylinositol 3-kinase (PI3K/Akt signaling
pathway important for cell survival), thereby activating
the antiapoptotic PI3 kinase/Akt pathway in primary
neurons.26 Activation of heme oxygenase-1 (HO-1) has
also been proposed as a mediator of cytoprotection
against NO-induced cytotoxicity.27 HO-1 is the rate-
limiting enzyme that catalyzes the conversion of heme
into biliverdin, endogenous carbon monoxide (CO), and
free iron. Forms of hemoxygenase identified, to date,
include the inducible HO-1 and constitutive HO-2 and
H0-3. Some evidence suggests that the overexpression
of HO-1 contributes to pathological iron deposition
supporting a detrimental role of HO-1.28 However, a
growing body of evidence suggests that HO-1 confers
cytoprotection against oxidative stress in a number of
models.29–31 Postmortem studies conducted in humans
have revealed increase in HO-1 protein in association
with Alzheimer disease, Parkinson disease and Hunt-
ington disease. A number of studies indicate that
overexpression of HO-1 decreases the neurotoxin-
induced cell death in transgenic mice and neuronal
cultures supporting a cytoprotective role of HO-1.27
CO can exert potent anti-inflammatory effects in
animal and cell culture models of sepsis, liver and
lung injury.27–31 The protection afforded by CO against
inflammatory lung injury and liver failure was associ-
ated with modulation of inducible nitric oxide syn-
thase.30,31 and in human pulp cells, HO-1-induced
cGMP conferred cytoprotection against NO-induced
cyotoxicity.32 Elucidating the mechanism(s) underly-
ing the apparent prosurvival effect of NO on ICC in the
stomach will be an important area for future research,
including the fundamental question of whether NO is
acting directly or indirectly.
REGION-SPECIFIC DIFFERENCES IN THE
EXPRESSION OF ICC NETWORKS IN THE
MOUSE STOMACH
This is an important observation that supports the
need for mapping the ICC networks throughout the
stomach and, indeed, the rest of the GI tract. While
laborious to generate, it is evident that the regional
morphometric data on ICC networks will be required
to provide the foundation for future studies that
focus on the physiological and pathophysiological
significance of these observations. It is also quite
possible that species differences will be observed in
the regional distribution of ICC networks, necessita-
ting a need to validate the mapping of ICC networks
in each species.
SUMMARY
Since its emergence as a major novel modulator of
cellular function, elucidating the physiologic and
pathophysiologic role(s) of nitric oxide has resulted
in numerous paradigm shifting observations in the
biomedical sciences including the likelihood that
other inorganic gaseous molecules, such as CO, have
potentially important roles in physiology and patho-
physiology. The paper by Choi et al. in this issue of
Neurogastroenterology and Motility provides the
foundation that nitric oxide has a prosurvival effect
on ICC cells in the mouse stomach and serves as a
reminder that there will likely be other faces of
nitric oxide’s biologic actions to be discovered in the
future.
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